Medical Devices: Page 72
-
Illumina cuts workforce by 5% amid supply chain woes, sales slowdown
The layoffs come as the firm wrestles with flat growth and a possible forced divestiture of its GRAIL cancer-detection unit.
By Nick Paul Taylor • Nov. 15, 2022 -
HHS cybersecurity center warns of new ransomware threat
Venus ransomware has attacked targets worldwide, including at least one U.S. health group, since it was first identified in mid-August.
By Susan Kelly • Nov. 14, 2022 -
Explore the Trendline➔
Sara Silbiger via Getty ImagesTrendlineTop 5 stories from MedTech Dive
From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics
Patients with Type 2 diabetes spent 3.6 hours per day longer in the target blood glucose range after switching to Tandem’s system, a study found.
By Nick Paul Taylor • Nov. 14, 2022 -
Mayo Clinic creates product to test AI models for bias and inaccuracy
The proliferation of AI models has led to concerns about whether they work as intended.
By Nick Paul Taylor • Nov. 14, 2022 -
Green light shows promise in addressing oximetry racial bias: study
Researchers created a noninvasive device that performed comparably to Abbott’s invasive i-STAT in a small clinical trial.
By Nick Paul Taylor • Nov. 14, 2022 -
GE HealthCare prices offering of $8.25B in bonds as part of spinoff
The GE unit is stepping up its preparations to operate as an independent company.
By Nick Paul Taylor • Nov. 11, 2022 -
BD says inflationary pressures persist; COVID-19 test sales plunge
Revenue at the company’s medical segment grew in the fourth quarter, helped by the acquisition of pharmacy automation company Parata.
By Elise Reuter • Nov. 10, 2022 -
Medtech execs ‘rethink’ long-term strategies as care settings shift: Accenture report
The move from hospitals to ambulatory and at-home care is only just beginning, the survey found.
By Nick Paul Taylor • Nov. 10, 2022 -
J&J names Tezel global head of medtech R&D as Shen retires
The executive will take up the post as the company says it’s looking to innovation for future profits.
By Nick Paul Taylor • Nov. 10, 2022 -
Affordable alternative: Smartphone-based hearing test for infants targets developing countries
The off-the-shelf alternative has a material cost of $10, giving children in impoverished regions easier access to vital monitoring and diagnosis.
By Nick Paul Taylor • Nov. 9, 2022 -
Lilly’s new diabetes management platform to integrate Dexcom CGM
The launch comes seven years after the company began investing in device R&D to counter pricing pressures.
By Nick Paul Taylor • Nov. 9, 2022 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers beats sales forecasts on imaging demand as diagnostic pressures prompt restructuring
Siemens Healthineers is revamping its diagnostics unit after concluding that “external headwinds [are] outweighing operational improvements.”
By Nick Paul Taylor • Nov. 9, 2022 -
Medtronic misses primary endpoint in renal denervation study
The device didn't outperform drug therapy when patients measured their blood pressure at home, though it's still expected to win FDA approval.
By Elise Reuter • Nov. 8, 2022 -
Verily’s Onduo cut blood sugar in retrospective study of Type 2 diabetics
Participants with high blood sugar at baseline benefited the most from Onduo, a study found.
By Nick Paul Taylor • Nov. 8, 2022 -
Power play: How harvesting energy from lungs may end need to replace batteries in brain stimulators
Researchers, aiming to prolong the life of powered devices that stimulate vital organs, are looking to bio-mechanics while also reducing the need for regular surgery to change batteries.
By Nick Paul Taylor • Nov. 8, 2022 -
Medtronic’s AFib ablation device beats antiarrhythmic drugs in 3-year study
Arctic Front cryoablation devices show promise as an early treatment for atrial fibrillation.
By Nick Paul Taylor • Nov. 8, 2022 -
iRhythm analysis shows savings from patients wearing Zio XT cardiac monitor patch
Scientists who performed the study say using the patch will save healthcare systems money by enabling early diagnosis.
By Peter Green • Nov. 7, 2022 -
5 takeaways from the FDA’s list of AI-enabled medical devices
As the number of devices increases, the agency is looking to adapt its regulatory framework to the new technology, including faster approval of algorithm updates.
By Elise Reuter • Nov. 7, 2022 -
Insulet reports record number of new customers on Omnipod 5 launch; shares climb
The company had the highest U.S. Omnipod revenue growth in a decade and also unveiled a new basal-insulin only pump.
By Elise Reuter • Nov. 4, 2022 -
Q&A
Friday Q&A: FemTech Focus’s Barreto discusses women’s health innovations, funding challenges
The executive director of the nonprofit group explains why women's health is finally getting attention and what the FemTech revolution is all about.
By Susan Kelly • Nov. 4, 2022 -
Teleflex recall of respiratory filters labeled Class I by FDA
The filters may split or detach from hospital respirators, disrupting airflow to patients and potentially causing death, the agency says.
By Peter Green • Nov. 4, 2022 -
Q&A
Q&A: Nuheara CEO talks about market potential for OTC hearing aids
John Luna discusses how the FDA’s new category of medical-quality, non-prescription hearing aids is poised to change the market.
By Peter Green • Nov. 3, 2022 -
Zimmer Q3 profit advances on higher sales of hip, knee joints
Analysts say the firm is grabbing market share, positioning it to recover income lost due to the pandemic-driven decline in elective procedures.
By Peter Green • Nov. 3, 2022 -
iRhythm narrowed loss in Q3 on higher sales of cardiac wearables
Revised CMS reimbursement rates may boost the earnings potential for the company’s wearable heart monitors.
By Peter Green • Updated Nov. 4, 2022 -
BioIntelliSense adds skin-color sensitivity to pulse oximeter chips amid FDA concerns over fingertip devices
An IT-driven blood-oxygen meter may help reduce a racial disparity in care caused by erroneous readings.
By Peter Green • Updated Nov. 2, 2022